Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/5/24 19:51 | 9/5/24 | ATHA | Health | BioPrd | Biological Products, (No Diag | Gengos Andrew | WA | O | CFO,CHIE | 1 | S | -1 | 0.5660 | 0 | -1 | 98 | D | |||||||||||||||
9/5/24 19:50 | 9/5/24 | ATHA | Health | BioPrd | Biological Products, (No Diag | Lenington Rachel | WA | O | COO,CDO | 1 | S | -1 | 0.5659 | 0 | -3 | 21 | D | |||||||||||||||
9/5/24 19:49 | 9/5/24 | ATHA | Health | BioPrd | Biological Products, (No Diag | Church Kevin | WA | O | Chief Sc | 1 | S | -1 | 0.5659 | 0 | -3 | 93 | D | |||||||||||||||
9/5/24 19:48 | 9/5/24 | ATHA | Health | BioPrd | Biological Products, (No Diag | Worthington Mark | WA | O | GC | 1 | S | -1 | 0.5659 | 0 | -3 | 52 | D | |||||||||||||||
9/5/24 19:47 | 9/5/24 | ATHA | Health | BioPrd | Biological Products, (No Diag | Litton Mark James | WA | DO | P,CEO | 1 | S | -3 | 0.5660 | 0 | -5 | 179 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |